Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient

MeSH terms

• 2-Naphthylamine
• Anilides / therapeutic use
• Antiviral Agents / blood
• Antiviral Agents / pharmacokinetics*
• Antiviral Agents / therapeutic use*
• Carbamates / therapeutic use
• Cyclopropanes
• Drug Interactions
• Drug Therapy, Combination
• HIV Infections* / drug therapy
• HIV Infections* / metabolism
• HIV Infections* / surgery
• Hepatitis C, Chronic* / drug therapy
• Hepatitis C, Chronic* / metabolism
• Hepatitis C, Chronic* / surgery
• Humans
• Lactams, Macrocyclic
• Liver Transplantation*
• Macrocyclic Compounds / therapeutic use
• Male
• Middle Aged
• Proline / analogs & derivatives
• Raltegravir Potassium / blood
• Raltegravir Potassium / pharmacokinetics*
• Raltegravir Potassium / therapeutic use
• Ritonavir / therapeutic use
• Sulfonamides / therapeutic use
• Uracil / analogs & derivatives
• Uracil / therapeutic use
• Valine